GleamWall
中文EN

UFPT UFP TECHNOLOGIES INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 914156 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.6%
TTM net income YoY14.0%
TTM EPS YoY13.7%
Revenue 3-yr CAGR18.6%
Net income 3-yr CAGR22.4%

Margins

Gross margin28.9%
Operating margin15.5%
Net margin11.8%
FCF margin—
EBITDA margin18.5%

Returns

ROE17.2%
ROA11.5%
ROIC (approx.)15.0%
Asset turnover0.97x

Leverage & solvency

Liabilities / assets28.8%
Debt / equity0.20x
Current ratio2.98x
Interest coverage14.64x

Cash quality & payout

Operating cash flow / net income0.97x
Accruals ratio0.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q42025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q42024-12-31
Income statement
Revenue$172.43M$173.96M$154.20M$148.91M$154.56M$151.18M$148.15M$144.07M
Cost of revenue$121.67M$123.05M$109.84M$106.95M$111.81M$107.63M$106.00M$102.01M
Gross profit$50.76M$50.92M$44.36M$41.97M$42.75M$43.54M$42.15M$42.06M
SG&A expense$23.15M$22.75M$21.02M$20.96M$19.07M$18.68M$18.73M$18.62M
Operating income$27.61M$28.10M$23.37M$21.50M$23.38M$24.33M$23.13M$22.26M
Interest expense$1.49M$1.71M$1.74M$1.93M$2.39M$2.67M$2.81M$3.38M
Pretax income$26.12M$26.43M$21.61M$19.54M$21.06M$21.63M$20.28M$19.10M
Income tax$5.50M$5.58M$4.11M$1.98M$4.68M$4.45M$3.10M$2.72M
Net income$20.62M$20.85M$17.50M$17.57M$16.38M$17.18M$17.18M$16.38M
EBITDA$30.13M$30.59M$25.79M$33.71M$20.97M$29.05M$25.37M$31.12M
EPS (basic)2.662.692.272.282.122.232.242.13
EPS (diluted)2.642.682.242.252.112.212.212.10
Weighted avg. shares (diluted)7.81M7.79M7.80M—7.78M7.77M7.78M—
Balance sheet
Cash & equivalents$20.62M$9.04M$19.98M$20.30M$18.23M$14.89M$14.03M$13.45M
Receivables$97.15M$113.25M$98.57M$82.91M$85.18M$84.93M$93.78M$84.68M
Inventory$98.15M$100.09M$93.98M$86.86M$86.15M$85.20M$89.84M$87.54M
Current assets$230.64M$234.89M$224.11M$201.00M$197.97M$191.39M$205.89M$194.94M
PP&E, net$78.58M$76.92M$78.40M$79.11M$77.54M$73.92M$71.51M$70.56M
Goodwill$198.88M$196.44M$196.65M$197.40M$197.30M$192.97M$190.56M$189.66M
Intangibles$136.19M$135.25M$137.86M$140.85M$143.26M$141.97M$141.97M$144.25M
Total assets$682.63M$681.91M$674.68M$655.08M$652.82M$634.66M$642.64M$629.00M
Current liabilities$77.36M$78.30M$77.01M$74.86M$82.23M$69.19M$79.87M$76.30M
Short-term debt$12.50M$12.50M$12.50M$12.50M$12.50M$12.50M$12.50M$12.50M
Long-term debt$83.50M$104.81M$125.11M$122.95M$133.62M$151.12M$163.62M$176.88M
Total debt$96.00M$117.31M$137.61M$135.46M$146.12M$163.62M$176.12M$189.38M
Total liabilities$196.92M$219.48M$235.81M$231.20M$248.91M$249.17M$281.97M$286.24M
Shareholders' equity$485.71M$462.43M$438.88M$423.88M$403.91M$385.49M$360.67M$342.76M
Net debt$75.38M$108.26M$117.63M$115.15M$127.89M$148.73M$162.10M$175.93M
Shares outstanding7.75M7.75M7.74M7.71M7.71M—7.71M7.68M
Cash flow statement
Operating cash flow$38.54M$15.61M$3.20M$16.84M$35.92M$25.33M$13.81M$24.42M
Capital expenditure—————$2.86M$2.82M$3.01M
Free cash flow—————$22.47M$10.99M$21.42M
Investing cash flow-$10.87M-$1.10M-$1.69M-$3.86M-$15.27M-$5.65M-$2.82M-$3.88M
Financing cash flow-$16.06M-$25.36M-$1.62M-$10.88M-$17.49M-$19.08M-$10.70M-$22.72M
Depreciation & amortization$2.52M$2.49M$2.42M$12.20M-$2.40M$4.72M$2.25M$8.86M
Stock-based compensation$2.79M$3.22M$2.73M$2.40M$1.96M$2.29M$2.21M$2.06M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.